Car-T Therapy for Patients Resistant to Proteasome Inhibitors
Discover how CAR-T therapy revolutionizes treatment for multiple myeloma resistant to proteasome inhibitors, offering hope and personalized care for patients. Explore the process, benefits, and key preparations.